• No results found

A comparison between uni- and multidimensional frailty measures: prevalence, functional status, and relationships with disability

N/A
N/A
Protected

Academic year: 2020

Share "A comparison between uni- and multidimensional frailty measures: prevalence, functional status, and relationships with disability"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Main characteristics of participants
Table 2 Differences in the functional status according to frailty measures
Table 3 relationship between uni- and multidimensional frailty measures and disability
Figure 2 rOC curves for prediction of disability with Chs index and TFI.Note: The gray diagonal line indicates a reference AUC of 0.50 (no better than chance alone).Abbreviations: gArs, groningen Activity restriction scale; Chs, Cardiovascular health study; AUC, areas under the curve; TFI, Tilburg Frailty Indicator; rOC, receiver operating characteristic.

References

Related documents

To answer the first research question “What Impact does the Hybrid Model have on the EFL vocabulary learning of students on Preparatory Year Program (PYP) at

Time- and fl uid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care

This essay draws on Piaget and Feldenkrais to argue that theorizing and working with diversity in students’ subjective constructions of movement is important for teaching and

Volunteer Measuring Official (VMO) or an Agility Field Rep is present; ALL dogs without a valid Jump Height Card/Form must be measured at some time during the trial or cluster

n Based on 2002 data, the combined number of people crossing north through the two local POEs of San Ysidro and Otay Mesa ( 8 miles from each other ) was equivalent to nearly 75%

Charaka Samhita: - With the Ayurveda - Dipika Commentary of Chakrapanidatta, edited by Vaidya Jadhavji Trikamji Acharya, Chaukhambha Surbharati Prakashana, Varanasi,

While some advances relate solely to small molecule or large molecule (biologic) production – primary or secondary manufacturing – biopharmaceutical manufacturers are

500 a day and is applicable to all cities and towns with a population less than 1 million (10 lakhs). It suggests a work list, to be implemented by the relevant urban